Willow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 16th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) — Willow Biosciences Inc. (TSX: WLLW, OTCQX: CANSF), based in Vancouver, Canada and is a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, today announced that Trevor Peters, President & Chief Executive Officer, will present live at LifeSciencesInvestorForum.com on September 16th.
DATE: Thursday, September 16th
TIME: 11:00 AM ET
LINK: https://bit.ly/3mKt7tj
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.lifesciencesinvestorforum.com.
Recent Company Highlights
- Recently commercialized first cannabinoid, cannabigerol (CBG)
- Signed first multi-year sales agreement in June 2021
- Recently added cannabinol (CBN) to growing portfolio of cannabinoids for development
- Have $40.7mm of cash on hand and no debt
About Willow Biosciences Inc.
Willow is a leading biotechnology company based in that develops and produces high-purity, plant derived ingredients for the consumer care, food and beverage, and pharmaceutical markets. Willow’s biotechnology platform allows creation of a consistent, scalable and sustainable product that benefits both B2B and B2C customers. Willow’s R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT: CONTACTS: Willow Biosciences Inc. Troy Talkkari Vice President, Corporate Development 403.618.1117 t.talkkari@willowbio.com Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com
